Recent innovations in mRNA vaccines

mRNA-based therapeutics--developing a new class of drugs

Sahin, U., Karikó, K., & Türeci, Ö. (2014) · Nature Reviews Drug Discovery · doi:10.1038/nrd4278 · Cited by 2,474 · see citing works

Safety, efficacy, and immunogenicity of VGX-3100, a therapeutic synthetic DNA vaccine targeting human papillomavirus 16 and 18 E6 and E7 proteins for cervical intraepithelial neoplasia 2/3: a randomised, double-blind, placebo-controlled phase 2b trial

Trimble, C. L., Morrow, M. P., Kraynyak, K. A., Shen, X., Dallas, M. J., Yan, J., Edwards, L., Parker, R. L., Denny, L., Giffear, M., et al. (2015) · The Lancet · doi:10.1016/s0140-6736(15)00239-1 · Cited by 732 · see citing works

Sequence-engineered mRNA without chemical nucleoside modifications enables an effective protein therapy in large animals

Thess, A., Grund, S., Mui, B. L., Hope, M. J., Baumhof, P., Fotin-Mleczek, M., & Schlake, T. (2015) · Molecular Therapy · doi:10.1038/mt.2015.103 · Cited by 513 · cited 1× · see citing works

A critical analysis of codon optimization in human therapeutics

Mauro, V. P., & Chappell, S. A. (2014) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2014.09.003 · Cited by 343 · see citing works

A Cationic Nanoemulsion for the Delivery of Next-generation RNA Vaccines

Brito, L. A., Chan, M., Shaw, C. A., Hekele, A., Carsillo, T., Schaefer, M., Archer, J., Seubert, A., Otten, G. R., Beard, C. W., et al. (2014) · Molecular Therapy · doi:10.1038/mt.2014.133 · Cited by 338 · see citing works

Self-adjuvanted mRNA vaccination in advanced prostate cancer patients: a first-in-man phase I/IIa study

Kübler, H., Scheel, B., Gnad-Vogt, U., Miller, K., Schultze-Seemann, W., vom Dorp, F., Parmiani, G., Hampel, C., Wedel, S., Trojan, L., et al. (2015) · Journal for Immunotherapy of Cancer · doi:10.1186/s40425-015-0068-y · Cited by 287 · see citing works

mRNA transcript therapy

Weissman, D. (2015) · Expert Review of Vaccines · doi:10.1586/14760584.2015.973859 · Cited by 228 · see citing works

RNA-Based Vaccines in Cancer Immunotherapy

McNamara, M. A., Nair, S. K., & Holl, E. K. (2015) · Journal of Immunology Research · doi:10.1155/2015/794528 · Cited by 223 · see citing works

Lipid-based mRNA vaccine delivery systems

Midoux, P., & Pichon, C. (2014) · Expert Review of Vaccines · doi:10.1586/14760584.2015.986104 · Cited by 209 · see citing works

RNA: The new revolution in nucleic acid vaccines

Geall, A. J., Mandl, C. W., & Ulmer, J. B. (2013) · Seminars in Immunology · doi:10.1016/j.smim.2013.05.001 · Cited by 187 · see citing works

Self-Amplifying mRNA Vaccines

Brito, L. A., Kommareddy, S., Maione, D., Uematsu, Y., Giovani, C., Scorza, F. B., Otten, G. R., Yu, D. L., Mandl, C. W., Mason, P. W., et al. (2014) · Advances in genetics · doi:10.1016/bs.adgen.2014.10.005 · Cited by 182 · see citing works

mRNA-based dendritic cell vaccines

Benteyn, D., Heirman, C., Bonehill, A., Thielemans, K., & Breckpot, K. (2014) · Expert Review of Vaccines · doi:10.1586/14760584.2014.957684 · Cited by 181 · see citing works

Potent Immune Responses in Rhesus Macaques Induced by Nonviral Delivery of a Self-amplifying RNA Vaccine Expressing HIV Type 1 Envelope With a Cationic Nanoemulsion

Bogers, W. M., Oostermeijer, H., Mooij, P., Koopman, G., Verschoor, E. J., Davis, D., Ulmer, J. B., Brito, L. A., Cu, Y., Banerjee, K., et al. (2015) · Journal of Infectious Diseases · doi:10.1093/infdis/jiu522 · Cited by 181 · see citing works

Nucleic acid vaccines: prospects for non-viral delivery of mRNA vaccines

Deering, R. P., Kommareddy, S., Ulmer, J. B., Brito, L. A., & Geall, A. J. (2014) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.2014.901308 · Cited by 177 · see citing works

Determinants and implications of mRNA poly(A) tail size – Does this protein make my tail look big?

Jalkanen, A. L., Coleman, S. J., & Wilusz, J. (2014) · Seminars in Cell & Developmental Biology · doi:10.1016/j.semcdb.2014.05.018 · Cited by 154 · see citing works

Induction of Broad-Based Immunity and Protective Efficacy by Self-amplifying mRNA Vaccines Encoding Influenza Virus Hemagglutinin

Brazzoli, M., Magini, D., Bonci, A., Buccato, S., Giovani, C., Kratzer, R., Zurli, V., Mangiavacchi, S., Casini, D., Brito, L. M., et al. (2016) · Journal of Virology · doi:10.1128/jvi.01786-15 · Cited by 154 · see citing works

Phase Ib study evaluating a self-adjuvanted mRNA cancer vaccine (RNActive®) combined with local radiation as consolidation and maintenance treatment for patients with stage IV non-small cell lung cancer

Sebastian, M., Papachristofilou, A., Weiß, C., Früh, M., Cathomas, R. L., Hilbe, W., Wehler, T., Rippin, G., Koch, S. D., Scheel, B., et al. (2014) · BMC Cancer · doi:10.1186/1471-2407-14-748 · Cited by 142 · see citing works

Self-replicating alphavirus RNA vaccines

Ljungberg, K., & Liljeström, P. (2014) · Expert Review of Vaccines · doi:10.1586/14760584.2015.965690 · Cited by 137 · see citing works

Induction of HIV-1 gag specific immune responses by cationic micelles mediated delivery of gag mRNA

Zhao, M., Li, M., Zhang, Z., Gong, T., & Sun, X. (2016) · Drug Delivery · doi:10.3109/10717544.2015.1038856 · Cited by 132 · see citing works

Intranasal mRNA nanoparticle vaccination induces prophylactic and therapeutic anti-tumor immunity

Phua, K. K. L., Staats, H. F., Leong, K. W., & Nair, S. K. (2014) · Scientific Reports · doi:10.1038/srep05128 · Cited by 123 · see citing works

A development that may evolve into a revolution in medicine: mRNA as the basis for novel, nucleotide-based vaccines and drugs

Kallen, K., & Theß, A. (2013) · Therapeutic Advances in Vaccines · doi:10.1177/2051013613508729 · Cited by 120 · see citing works

mRNA vaccine CV9103 and CV9104 for the treatment of prostate cancer

Rausch, S., Schwentner, C., Stenzl, A., & Bedke, J. (2014) · Human Vaccines & Immunotherapeutics · doi:10.4161/hv.29553 · Cited by 115 · see citing works

Polyethylenimine-based polyplex delivery of self-replicating RNA vaccines

Démoulins, T., Milona, P., Englezou, P. C., Ebensen, T., Schulze, K., Suter, R., Pichon, C., Midoux, P., Guzmán, C. A., Ruggli, N., et al. (2015) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2015.11.001 · Cited by 107 · see citing works

The 5′ and 3′ ends of alphavirus RNAs – Non-coding is not non-functional

Hyde, J., Chen, R., Trobaugh, D. W., Diamond, M., Weaver, S. C., Klimstra, W. B., & Wilusz, J. (2015) · Virus Research · doi:10.1016/j.virusres.2015.01.016 · Cited by 105 · see citing works

The ReNAissanCe of mRNA-based cancer therapy

Van Lint, S., Renmans, D., Broos, K., Dewitte, H., Lentacker, I., Heirman, C., Breckpot, K., & Thielemans, K. (2015) · Expert Review of Vaccines · doi:10.1586/14760584.2015.957685 · Cited by 95 · see citing works

CD 8 T‐cell priming upon mRNA vaccination is restricted to bone‐marrow‐derived antigen‐presenting cells and may involve antigen transfer from myocytes

Lazzaro, S., Giovani, C., Mangiavacchi, S., Magini, D., Maione, D., Baudner, B. C., Geall, A. J., Gregorio, E. D., D’Oro, U., & Buonsanti, C. (2015) · Immunology · doi:10.1111/imm.12505 · Cited by 88 · see citing works

A novel RNA‐based adjuvant combines strong immunostimulatory capacities with a favorable safety profile

Heidenreich, R., Jasny, E., Kowalczyk, A., Lutz, J., Probst, J., Baumhof, P., Scheel, B., Voss, S., Kallen, K., & Fotin‐Mleczek, M. (2014) · International Journal of Cancer · doi:10.1002/ijc.29402 · Cited by 80 · see citing works

Human cytomegalovirus gH/gL/UL128/UL130/UL131A complex elicits potently neutralizing antibodies in mice

Wen, Y., Monroe, J. E., Linton, C. E., Archer, J. F., Beard, C. W., Barnett, S. W., Palladino, G., Mason, P. W., Carfı́, A., & Lilja, A. E. (2014) · Vaccine · doi:10.1016/j.vaccine.2014.05.004 · Cited by 80 · see citing works

Development of nucleic acid vaccines: use of self-amplifying RNA in lipid nanoparticles

Rodríguez‐Gascón, A., del Pozo‐Rodríguez, A., & Solinís, M. Á. (2014) · International Journal of Nanomedicine · doi:10.2147/ijn.s39810 · Cited by 79 · see citing works

Intratumoral administration of mRNA encoding a fusokine consisting of IFN-β and the ectodomain of the TGF-β receptor II potentiates antitumor immunity

der Jeught, K. V., Joe, P. T., Bialkowski, L., Heirman, C., Daszkiewicz, L., Liechtenstein, T., Escors, D., Thielemans, K., & Breckpot, K. (2014) · Oncotarget · doi:10.18632/oncotarget.2463 · Cited by 79 · see citing works

Self-replicating Replicon-RNA Delivery to Dendritic Cells by Chitosan-nanoparticles for Translation In Vitro and In Vivo

McCullough, K. C., Bassi, I., Milona, P., Suter, R., Thomann, L., Englezou, P. C., Démoulins, T., & Ruggli, N. (2014) · Molecular Therapy — Nucleic Acids · doi:10.1038/mtna.2014.24 · Cited by 72 · see citing works

Enhancement of protein expression by alphavirus replicons by designing self-replicating subgenomic RNAs

Kim, D. Y., Atasheva, S., McAuley, A. J., Plante, J. A., Frolova, E. I., Beasley, D. W. C., & Frolov, I. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1408677111 · Cited by 57 · see citing works

Vaccines ‘on demand’: science fiction or a future reality

Ulmer, J. B., Mansoura, M. K., & Geall, A. J. (2015) · Expert Opinion on Drug Discovery · doi:10.1517/17460441.2015.996128 · Cited by 45 · see citing works

Control of alphavirus-based gene expression using engineered riboswitches

Bell, C. L., Yu, D. L., Smolke, C. D., Geall, A. J., Beard, C. W., & Mason, P. W. (2015) · Virology · doi:10.1016/j.virol.2015.04.023 · Cited by 44 · see citing works

A Kunjin Replicon Virus-like Particle Vaccine Provides Protection Against Ebola Virus Infection in Nonhuman Primates

Pyankov, O. V., Боднев, С. А., Pyankova, O. G., Solodky, V. V., Pyankov, S. A., Setoh, Y. X., Volchkova, V. A., Suhrbier, A., Volchkov, V. E., Agafonov, A. P., et al. (2015) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiv019 · Cited by 44 · see citing works

mRNA-based vaccines synergize with radiation therapy to eradicate established tumors

Fotin‐Mleczek, M., Zanzinger, K., Heidenreich, R., Lorenz, C., Kowalczyk, A., Kallen, K., & Huber, S. M. (2014) · Radiation Oncology · doi:10.1186/1748-717x-9-180 · Cited by 44 · see citing works

Translation of genomics-guided RNA-based personalised cancer vaccines: towards the bedside

Boisguérin, V., Castle, J. C., Löewer, M., Diekmann, J., Mueller, F., Britten, C. M., Kreiter, S., Türeci, Ö., & Şahin, U. (2014) · British Journal of Cancer · doi:10.1038/bjc.2013.820 · Cited by 42 · see citing works

The messenger's great message for vaccination

Pascolo, S. (2015) · Expert Review of Vaccines · doi:10.1586/14760584.2015.1000871 · Cited by 40 · see citing works

Clinical Development of a Cytomegalovirus DNA Vaccine: From Product Concept to Pivotal Phase 3 Trial

Smith, L. R., Wloch, M. K., Chaplin, J., Gerber, M., & Rolland, A. P. (2013) · Vaccines · doi:10.3390/vaccines1040398 · Cited by 38 · see citing works

Kinetic and Phenotypic Analysis of CD8+ T Cell Responses after Priming with Alphavirus Replicons and Homologous or Heterologous Booster Immunizations

Knudsen, M., Ljungberg, K., Kakoulidou, M., Kostic, L., Hallengärd, D., García-Arriaza, J., Merits, A., Esteban, M., & Liljeström, P. (2014) · Journal of Virology · doi:10.1128/jvi.02223-14 · Cited by 36 · see citing works

Self-Amplifying Replicon RNA Vaccine Delivery to Dendritic Cells by Synthetic Nanoparticles

McCullough, K. C., Milona, P., Thomann, L., Démoulins, T., Englezou, P. C., Suter, R., & Ruggli, N. (2014) · Vaccines · doi:10.3390/vaccines2040735 · Cited by 33 · see citing works

A tetravalent alphavirus-vector based dengue vaccine provides effective immunity in an early life mouse model

Khalil, S. M., Tonkin, D. R., Mattocks, M. D., Snead, A. T., Johnston, R. E., & White, L. (2014) · Vaccine · doi:10.1016/j.vaccine.2014.05.053 · Cited by 32 · see citing works

Alphavirus-based Vaccines Encoding Nonstructural Proteins of Hepatitis C Virus Induce Robust and Protective T-cell Responses

Ip, P. P., Boerma, A., Regts, J., Meijerhof, T., Wilschut, J., Nijman, H. W., & Daemen, T. (2013) · Molecular Therapy · doi:10.1038/mt.2013.287 · Cited by 32 · see citing works

Prophylactic mRNA Vaccination against Allergy Confers Long-Term Memory Responses and Persistent Protection in Mice

Hattinger, E., Scheiblhofer, S., Roesler, E., Thalhamer, T., Thalhamer, J., & Weiss, R. (2015) · Journal of Immunology Research · doi:10.1155/2015/797421 · Cited by 28 · see citing works

Japanese encephalitis virus replicon-based vaccine expressing enterovirus-71 epitope confers dual protection from lethal challenges

Huang, Y.-T., Liao, J.-T., Yen, L.-C., Chang, Y.-K., Lin, Y., & Liao, C. (2015) · Journal of Biomedical Science · doi:10.1186/s12929-015-0181-8 · Cited by 22 · see citing works

Tattoo Delivery of a Semliki Forest Virus-Based Vaccine Encoding Human Papillomavirus E6 and E7

van de Wall, S., Walczak, M., van Rooij, N., Hoogeboom, B. N., Meijerhof, T., Nijman, H. W., & Daemen, T. (2015) · Vaccines · doi:10.3390/vaccines3020221 · Cited by 18 · see citing works

Evaluation of nonspreading Rift Valley fever virus as a vaccine vector using influenza virus hemagglutinin as a model antigen

Oreshkova, N., Cornelissen, L. A. H. M., de Haan, C. A. M., Moormann, R. J. M., & Kortekaas, J. (2014) · Vaccine · doi:10.1016/j.vaccine.2014.07.051 · Cited by 17 · see citing works

Introduction to RNA-based vaccines and therapeutics

Geall, A. J., & Ulmer, J. B. (2015) · Expert Review of Vaccines · doi:10.1586/14760584.2015.1001244 · Cited by 7 · see citing works

Paramyxovirus-based production of Rift Valley fever virus replicon particles

Schreur, P. J. W., Oreshkova, N., Harders, F., Bossers, A., Moormann, R. J. M., & Kortekaas, J. (2014) · Journal of General Virology · doi:10.1099/vir.0.067660-0 · Cited by 6 · see citing works

Current Developments in Actively Personalized Cancer Vaccination with a Focus on RNA as the Drug Format

Diken, M., Kreiter, S., Kloke, B., & Şahin, U. (2015) · Progress in tumor research · doi:10.1159/000437184 · Cited by 6 · see citing works

mRNA vaccines — a new era in vaccinology

Pardi, N., Hogan, M. J., Porter, F. W., & Weissman, D. (2018) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2017.243 · Cited by 4,667 · see citing works

Cancer nanomedicine for combination cancer immunotherapy

Nam, J., Son, S., Park, K. S., Zou, W., Shea, L. D., & Moon, J. J. (2019) · Nature Reviews Materials · doi:10.1038/s41578-019-0108-1 · Cited by 946 · see citing works

Advances in mRNA Vaccines for Infectious Diseases

Zhang, C., Maruggi, G., Shan, H., & Li, J. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.00594 · Cited by 680 · see citing works

Advances in the delivery of RNA therapeutics: from concept to clinical reality

Kaczmarek, J. C., Kowalski, P. S., & Anderson, D. G. (2017) · Genome Medicine · doi:10.1186/s13073-017-0450-0 · Cited by 656 · see citing works

The Limitless Future of RNA Therapeutics

Damase, T. R., Sukhovershin, R. A., Boada, C., Taraballi, F., Pettigrew, R. I., & Cooke, J. P. (2021) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2021.628137 · Cited by 549 · see citing works

Review of alternatives to antibiotic use in aquaculture

Bondad‐Reantaso, M. G., MacKinnon, B., Karunasagar, I., Fridman, S., Alday‐Sanz, V., Brun, E., Groumellec, M. L., Li, A., Surachetpong, W., Karunasagar, I., et al. (2023) · Reviews in Aquaculture · doi:10.1111/raq.12786 · Cited by 445 · see citing works

A Review of Fish Vaccine Development Strategies: Conventional Methods and Modern Biotechnological Approaches

Ma, J., Bruce, T. J., Jones, E. M., & Cain, K. D. (2019) · Microorganisms · doi:10.3390/microorganisms7110569 · Cited by 429 · see citing works

Unmodified mRNA in LNPs constitutes a competitive technology for prophylactic vaccines

Lutz, J., Lazzaro, S., Habbeddine, M., Schmidt, K. E., Baumhof, P., Mui, B. L., Tam, Y. K., Madden, T. D., Hope, M. J., Heidenreich, R., et al. (2017) · npj Vaccines · doi:10.1038/s41541-017-0032-6 · Cited by 257 · see citing works

Mechanism of action of mRNA-based vaccines

Iavarone, C., O’hagan, D. T., Yu, D., Delahaye, N. F., & Ulmer, J. B. (2017) · Expert Review of Vaccines · doi:10.1080/14760584.2017.1355245 · Cited by 234 · see citing works

Induction of an IFN-mediated antiviral response by a self-amplifying RNA vaccine: implications for vaccine design

Pepini, T., Pulichino, A.-M., Carsillo, T., Carlson, A. L., Sari-Sarraf, F., Ramsauer, K., Debasitis, J. C., Maruggi, G., Otten, G. R., Geall, A. J., et al. (2017) · The Journal of Immunology · doi:10.4049/jimmunol.1601877 · Cited by 208 · see citing works

COVID-19: Unmasking Emerging SARS-CoV-2 Variants, Vaccines and Therapeutic Strategies

Raman, R., Patel, K. J., & Ranjan, K. (2021) · Biomolecules · doi:10.3390/biom11070993 · Cited by 186 · see citing works

Clinical and immunological effects of mRNA vaccines in malignant diseases

Heine, A., Juranek, S., & Brossart, P. (2021) · Molecular Cancer · doi:10.1186/s12943-021-01339-1 · Cited by 185 · see citing works

Emerging viral diseases from a vaccinology perspective: preparing for the next pandemic

Graham, B. S., & Sullivan, N. J. (2017) · Nature Immunology · doi:10.1038/s41590-017-0007-9 · Cited by 177 · see citing works

Nanoscale platforms for messenger RNA delivery

Li, B., Zhang, X., & Dong, Y. (2019) · WIREs Nanomedicine and Nanobiotechnology · doi:10.1002/wnan.1530 · Cited by 170 · see citing works

Messenger RNA-based vaccines: Past, present, and future directions in the context of the COVID-19 pandemic

Jain, S., Venkataraman, A. K., Wechsler, M. E., & Peppas, N. A. (2021) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2021.114000 · Cited by 163 · see citing works

Antigen Presentation of mRNA-Based and Virus-Vectored SARS-CoV-2 Vaccines

Rijkers, G. T., Weterings, N., Obregón‐Henao, A., Dutt, T., Dutt, T. S., van Overveld, F. J., & Henao-Tamayo, M. I. (2021) · Vaccines · doi:10.3390/vaccines9080848 · Cited by 134 · see citing works

Induction of robust B cell responses after influenza mRNA vaccination Is accompanied by circulating hemagglutinin-specific ICOS+ PD-1+ CXCR3+ T follicular helper cells

Lindgren, G., Ols, S., Liang, F., Thompson, E. A., Lin, A., Hellgren, F., Bahl, K., John, S., Yuzhakov, O., Hassett, K. J., et al. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.01539 · Cited by 132 · see citing works

Aptamers: Cutting edge of cancer therapies

Shigdar, S. L., Schrand, B., Giangrande, P. H., & de Franciscis, V. (2021) · Molecular Therapy · doi:10.1016/j.ymthe.2021.06.010 · Cited by 128 · see citing works

Recent Advancements in Nanomedicine for ‘Cold’ Tumor Immunotherapy

Chen, Q., Sun, T., & Jiang, C. (2021) · Nano-Micro Letters · doi:10.1007/s40820-021-00622-6 · Cited by 113 · see citing works

The advent of clinical self-amplifying RNA vaccines

Casmil, I. C., Jin, J., Won, E.-J., Huang, C., Liao, S., Cha‐Molstad, H., & Blakney, A. K. (2025) · Molecular Therapy · doi:10.1016/j.ymthe.2025.03.060 · Cited by 105 · see citing works

COVID-19 mRNA vaccines

Huang, Q.-R., Zeng, J., & Yan, J.-H. (2021) · Journal of genetics and genomics = Yi chuan xue bao · doi:10.1016/j.jgg.2021.02.006 · Cited by 89 · see citing works

Modern biotechnological strategies for vaccine development in aquaculture – Prospects and challenges

Priya, T. A. J., & Kappalli, S. (2022) · Vaccine · doi:10.1016/j.vaccine.2022.08.075 · Cited by 86 · see citing works

Folate-Targeted mRNA Delivery Using Chitosan-Functionalized Selenium Nanoparticles: Potential in Cancer Immunotherapy

Maiyo, F., & Singh, M. (2019) · Pharmaceuticals · doi:10.3390/ph12040164 · Cited by 84 · see citing works

Current view on novel vaccine technologies to combat human infectious diseases

Matić, Z., & Šantak, M. (2021) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-021-11713-0 · Cited by 80 · see citing works

Novel Vaccine Technologies

Graham, B. S., Mascola, J. R., & Fauci, A. S. (2018) · JAMA · doi:10.1001/jama.2018.0345 · Cited by 79 · see citing works

Bacterial diseases in marine fish species: current trends and future prospects in disease management

Hegde, A., Kabra, S., Basawa, R., Khile, D. A., Abbu, R. U. F., Thomas, N. A., Manickam, N. B., & Raval, R. (2023) · World Journal of Microbiology and Biotechnology · doi:10.1007/s11274-023-03755-5 · Cited by 76 · see citing works

Tumor Vaccines: Unleashing the Power of the Immune System to Fight Cancer

Liu, D., Che, X., Wang, X., Ma, C., & Wu, G. (2023) · Pharmaceuticals · doi:10.3390/ph16101384 · Cited by 76 · see citing works

Towards the future exploration of mucosal mRNA vaccines against emerging viral diseases; lessons from existing next-generation mucosal vaccine strategies

Hameed, S. A., Paul, S., Dellosa, G. K. Y., Jaraquemada, D., & Bello, M. B. (2022) · npj Vaccines · doi:10.1038/s41541-022-00485-x · Cited by 64 · see citing works

mRNA vaccines: a new era in vaccine development

Chandra, S., Wilson, J. C., Good, D. M., & Wei, M. Q. (2024) · Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics · doi:10.32604/or.2024.043987 · Cited by 58 · see citing works

Local and systemic delivery of mRNA encoding survivin-T34A by lipoplex for efficient colon cancer gene therapy

Zhang, X., Men, K., Zhang, Y., Zhang, R., Yang, L., & Duan, X. (2019) · International Journal of Nanomedicine · doi:10.2147/ijn.s198747 · Cited by 57 · see citing works

Neutral Lipopolyplexes for In Vivo Delivery of Conventional and Replicative RNA Vaccine

Perche, F., Clemençon, R., Schulze, K., Ebensen, T., Guzmán, C. A., & Pichon, C. (2019) · Molecular Therapy - Nucleic Acids · doi:10.1016/j.omtn.2019.07.014 · Cited by 55 · see citing works

High-Resolution capillary electrophoresis separation of large RNA under non-aqueous conditions

Lu, T., Klein, L. J., Ha, S., & Rustandi, R. R. (2020) · Journal of Chromatography A · doi:10.1016/j.chroma.2020.460875 · Cited by 53 · see citing works

Cholesterol-modified DP7 enhances the effect of individualized cancer immunotherapy based on neoantigens

Zhang, R., Tang, L., Tian, Y., Xiao, J., Hu, Q., Zhou, B., Zhenyu, D., Xu, H., & Yang, L. (2020) · Biomaterials · doi:10.1016/j.biomaterials.2020.119852 · Cited by 53 · see citing works

Tackling TNF-α in autoinflammatory disorders and autoimmune diseases: From conventional to cutting edge in biologics and RNA- based nanomedicines

Andretto, V., Dusi, S., Zilio, S., Repellin, M., Kryza, D., Ugel, S., & Lollo, G. (2023) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2023.115080 · Cited by 50 · see citing works

To React or Not to React: The Dilemma of Fish Immune Systems Facing Myxozoan Infections

Holzer, A. S., Piazzon, M. C., Barrett, D., Bartholomew, J. L., & Sitjà‐Bobadilla, A. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.734238 · Cited by 48 · see citing works

Immune Response Activation and Immunomodulation

Tyagi, R. K., & Bisen, P. S. (2019) · IntechOpen eBooks · doi:10.5772/intechopen.73708 · Cited by 44 · see citing works

Whither vaccines?

Rodrigues, C. M. C., Pinto, M. V., Sadarangani, M., & Plotkin, S. A. (2017) · Journal of Infection · doi:10.1016/s0163-4453(17)30184-6 · Cited by 33 · see citing works

RNA therapeutics for cardiovascular disease

Boada, C., Sukhovershin, R. A., Pettigrew, R. I., & Cooke, J. P. (2021) · Current Opinion in Cardiology · doi:10.1097/hco.0000000000000850 · Cited by 30 · see citing works

Advancing personalized medicine in brain cancer: exploring the role of mRNA vaccines

Lin, F., Lin, E. Z., Anekoji, M., Ichim, T. E., Hu, J. K., Marincola, F. M., Jones, L. D., Kesari, S., & Ashili, S. (2023) · Journal of Translational Medicine · doi:10.1186/s12967-023-04724-0 · Cited by 28 · see citing works

Quantitative study of RNA transmission through ultrafiltration membranes

Manzano, I., & Zydney, A. L. (2017) · Journal of Membrane Science · doi:10.1016/j.memsci.2017.09.042 · Cited by 28 · see citing works

Development of Middle East Respiratory Syndrome Coronavirus vaccines – advances and challenges

Cho, H., Excler, J., Kim, J. H., & Yoon, I. (2017) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2017.1389362 · Cited by 28 · see citing works

Methods for improving the immunogenicity and efficacy of cancer vaccines

Pilla, L., Ferrone, S., & Maccalli, C. (2018) · Expert Opinion on Biological Therapy · doi:10.1080/14712598.2018.1485649 · Cited by 26 · see citing works

UTRGAN: learning to generate 5′ UTR sequences for optimized translation efficiency and gene expression

Barazandeh, S., Özden, F., Hınçer, A., Şeker, U. Ö. Ş., & Çiçek, A. E. (2024) · Bioinformatics Advances · doi:10.1093/bioadv/vbaf134 · Cited by 23 · see citing works

Co-administration of GM-CSF expressing RNA is a powerful tool to enhance potency of SAM-based vaccines

Manara, C., Brazzoli, M., Piccioli, D., Taccone, M., D’Oro, U., Maione, D., & Frigimelica, E. (2019) · Vaccine · doi:10.1016/j.vaccine.2019.04.028 · Cited by 23 · see citing works

HIV and Messenger RNA Vaccine

Khalid, K., Padda, J., Khedr, A., Ismail, D., Zubair, U., Al-Ewaidat, O. A., Padda, S., Cooper, A. C., & Jean-Charles, G. (2021) · Cureus · doi:10.7759/cureus.16197 · Cited by 23 · see citing works

First International Precision Vaccines Conference: Multidisciplinary Approaches to Next-Generation Vaccines

Borriello, F., van Haren, S. D., & Levy, O. (2018) · mSphere · doi:10.1128/msphere.00214-18 · Cited by 18 · see citing works

Comparison of Antibody and T Cell Responses Induced by Single Doses of ChAdOx1 nCoV-19 and BNT162b2 Vaccines

Kim, J. Y., Bae, S., Park, S., Kwon, J., Lim, S. Y., Park, J. Y., Cha, H. H., Seo, M. H., Lee, H. J., Lee, N., et al. (2021) · Immune Network · doi:10.4110/in.2021.21.e29 · Cited by 14 · see citing works

mRNA vaccines and SiRNAs targeting cancer immunotherapy: challenges and opportunities

Lv, Z., & Dai, Y. (2025) · Discover Oncology · doi:10.1007/s12672-025-03070-5 · Cited by 14 · see citing works

Current State of the Art in DNA Vaccine Delivery and Molecular Adjuvants: Bcl-xL Anti-Apoptotic Protein as a Molecular Adjuvant

İz, S. G., & Saglam‐Metiner, P. (2019) · IntechOpen eBooks · doi:10.5772/intechopen.82203 · Cited by 14 · see citing works

Advances in RNA therapy for the treatment of autoimmune diseases

Zhang, Y., Zang, C., Mao, M., Zhang, M., Tang, Z., Chen, W., & Wu, Z. (2025) · Autoimmunity Reviews · doi:10.1016/j.autrev.2025.103753 · Cited by 12 · see citing works

Synthesis and Characterization of mRNA-Loaded Poly(Beta Aminoesters) Nanoparticles for Vaccination Purposes

Fornaguera, C., Díaz-Caballero, M., García-Fernández, C., Olmo, L., Pinto, M. S.-L., Navalón-López, M., Guerra‐Rebollo, M., & Borrós, S. (2021) · Journal of Visualized Experiments · doi:10.3791/62889 · Cited by 12 · see citing works

Hepatitis C virus DNA vaccines: a systematic review

Shayeghpour, A., Kianfar, R., Hosseini, P., Ajorloo, M., Aghajanian, S., Yaghoobi, M. H., Hashempour, T., & Mozhgani, S. (2021) · Virology Journal · doi:10.1186/s12985-021-01716-8 · Cited by 12 · see citing works

Messenger RNA Therapy for Female Reproductive Health

VanKeulen‐Miller, R., & Fenton, O. S. (2024) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.3c00803 · Cited by 12 · see citing works

Advantages and disadvantages of RNA therapeutics

Huy, B. L., Phuong, H. B. T., & Xuan, H. L. (2024) · Progress in molecular biology and translational science · doi:10.1016/bs.pmbts.2023.12.016 · Cited by 10 · see citing works

siRNA as potential therapeutic strategy for hypertension

Tanna, S., Doshi, G., & Godad, A. P. (2024) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2024.176467 · Cited by 9 · see citing works

Literature Mining and Mechanistic Graphical Modelling to Improve mRNA Vaccine Platforms

Leonardelli, L., Lofano, G., Selvaggio, G., Parolo, S., Giampiccolo, S., Tomasoni, D., Domenici, E., Priami, C., Song, H., Medini, D., et al. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.738388 · Cited by 9 · see citing works

Optimization of 5′UTR to evade SARS-CoV-2 Nonstructural protein 1-directed inhibition of protein synthesis in cells

Chen, S.-C., Xu, C.-T., Chang, C.-F., Chao, T.-Y., Lin, C., Fu, P.-W., & Yu, C. (2023) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-023-12442-2 · Cited by 8 · see citing works

Cyanuric chloride as the basis for compositionally diverse lipids

Nardo, D., Akers, C., Cheung, N. E., Isom, C. M., Spaude, J. T., Pack, D. W., & Venditto, V. J. (2021) · RSC Advances · doi:10.1039/d1ra02425f · Cited by 8 · see citing works

mRNA as a Therapeutics: Understanding mRNA Vaccines

Oğuz, F., & Atmaca, H. (2021) · Advanced Pharmaceutical Bulletin · doi:10.34172/apb.2022.028 · Cited by 7 · see citing works

RNA-Based Therapies in Kidney Diseases

Hu, L., Jin, T., Zhang, N., Ding, J. J., & Li, L. (2025) · Journal of Inflammation Research · doi:10.2147/jir.s505252 · Cited by 6 · see citing works

mRNA Manufacturing and Single‐use Technology – A Perfect Liaison

Grilo, A. L., & Schmidhalter, D. R. (2022) · Chemie Ingenieur Technik · doi:10.1002/cite.202200147 · Cited by 6 · see citing works

Non-interfacial self-assembly of synthetic protocells

Xu, X., Guan, W., Yu, X., Xu, G., & Wang, C. (2023) · Biomaterials Research · doi:10.1186/s40824-023-00402-w · Cited by 5 · see citing works

Thermally Robust Solvent-Free Liquid Polyplexes for Heat-Shock Protection and Long-Term Room Temperature Storage of Therapeutic Nucleic Acids

Chen, Y., Lin, X., Liu, X., Liu, Y., Bui‐Le, L., Blakney, A. K., Yeow, J., Zhu, Y., Stevens, M. M., Shattock, R. J., et al. (2024) · Biomacromolecules · doi:10.1021/acs.biomac.4c00117 · Cited by 4 · see citing works

Nanostrategies to Develop Current Antiviral Vaccines

Rodrigues, G. R., Sousa, M. G. D. C., da Silva, D. C., Rezende, T. M. B., Morais, P. C., & Franco, O. L. (2021) · ACS Applied Bio Materials · doi:10.1021/acsabm.0c01284 · Cited by 4 · see citing works

Modulating the immune response with liposomal delivery

Nardo, D., Henson, D. M., Springer, J. E., & Venditto, V. J. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-816705-2.00006-0 · Cited by 4 · see citing works

Novel approaches in preclinical HIV vaccine research

Safrit, J. T., & Koff, W. C. (2016) · Current Opinion in HIV and AIDS · doi:10.1097/coh.0000000000000318 · Cited by 3 · see citing works

RNA Vaccines: The Evolution, Applications, and the Challenges Ahead

Banerji, I., Bhattacharjee, S., Mukherjee, K., & Bhattacharyya, S. N. (2023) · Springer eBooks · doi:10.1007/978-981-19-8520-1_10 · Cited by 3 · see citing works

RNA therapeutics for regenerative medicine

Thi, Y. V. N., Ngo, A. D., Chu, D., Lin, S.-C., & Wu, C. (2024) · Progress in molecular biology and translational science · doi:10.1016/bs.pmbts.2023.12.002 · Cited by 3 · see citing works

Overcoming Hurdles to Development of a Vaccine against Pneumocystis jirovecii

Garvy, B. A. (2017) · Infection and Immunity · doi:10.1128/iai.00035-17 · Cited by 3 · see citing works

Biopharmaceutical molecules

Benyahia, B., Brumano, L. P., Pessoa, A., & da Silva, F. V. S. (2020) · Elsevier eBooks · doi:10.1016/b978-0-444-64301-8.00002-0 · Cited by 2 · see citing works

SARS-CoV-2 Leading Vaccine Candidates: Progress and Development

Amraiz, D., Fatima, M. T., & Navid, M. T. (2020) · Life and Science · doi:10.37185/lns.1.1.153 · Cited by 2 · see citing works

RNA therapies hold great promise for treating cancer. High-throughput screening techniques have facilitated the development of RNA treatmentsPreprint

Dowaidar, M. (2021) · doi:10.31219/osf.io/9vxrb · Cited by 2 · see citing works

Harnessing the Immune System to Target Cancer Cells

Maccalli, C. (2019) · Resistance to targeted anti-cancer therapeutics · doi:10.1007/978-3-030-16624-3_6 · Cited by 1 · see citing works

Harnessing mRNA vaccines for viral diseases: bottleneck and breakthrough

Mishra, V. K., Ranjan, A., & Mishra, Y. (2025) · Exploration of Immunology · doi:10.37349/ei.2025.1003212 · Cited by 1 · see citing works

BACTERIAL DISEASES OF FISH IN AQUACULTURE: A REVIEW OF PATHOGENS AND CONTROL STRATEGIES

YESSENTUREYEVA, М. О., Киркимбаева, Ж. С., Sarybayeva, D. A., KASSYMBEKOV, Y. T., Ruzˇauskas, M., & Kydyrmanov, A. I. (2026) · МИКРОБИОЛОГИЯ ЖӘНЕ ВИРУСОЛОГИЯ · doi:10.53729/mv-as.2026.02.04 · Cited by 1 · see citing works

mRNA Based Vaccine Studies in Infectious Diseases and Current Developments

Savaşçı, Ü., & Gül, H. C. (2021) · Journal of Molecular Virology and Immunology · doi:10.46683/jmvi.2020.19 · Cited by 1 · see citing works

Rational design of an EDIII mRNA vaccine candidate against Zika virus

Tian, Y., Wu, M., Li, K., Chao Hui, Z. H. O. U., Zhang, R., Zhou, H., Ye, Q., Qin, C., Huang, S., & Li, X.-F. (2023) · Chinese Science Bulletin (Chinese Version) · doi:10.1360/tb-2023-0369 · Cited by 1 · see citing works

RNA therapeutics for infectious diseases

Tu, L. M. T. P. P. L. M., Pham, T. T. D., & Than, V. T. (2024) · Progress in molecular biology and translational science · doi:10.1016/bs.pmbts.2024.01.002 · Cited by 1 · see citing works

Navigating the horizon of mRNA vaccines: Tracing their evolution, ensuring safety, and unveiling therapeutic potential

Yap, E. C. T. (2023) · International e-Journal of Science Medicine & Education · doi:10.56026/imu.17.3.13 · Cited by 1 · see citing works

In-vivo Delivery of mRNA-Based Vaccines and Administration Routes

Gümral, R. (2021) · Journal of Molecular Virology and Immunology · doi:10.46683/jmvi.2020.16 · Cited by 1 · see citing works

Molecular imprinting and surface grafting of glycoprotein fragments in polymeric nanosystems: from cancer diagnosis to virus targeting

Bzainia, A., Gomes, C. P., Dias, R. C. S., & Costa, M. R. P. F. N. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-85656-0.00012-7 · Cited by 1 · see citing works

Current State of mRNA Vaccine Development Against Mycobacterium tuberculosis

Aernout, I., Verbeke, R., Smedt, S. C. D., Impens, F., & Lentacker, I. (2024) · Wiley eBooks · doi:10.1002/9783527838394.ch12 · Cited by 1 · see citing works

Modern Production Strategies in the Vaccine Industry

Pujar, H., & Lundgren, M. (2018) · Elsevier eBooks · doi:10.1016/b978-0-08-100623-8.00040-2

From Foe to Friend: Therapeutic and Commercial Applications of Engineered Viruses

DeHart, J. L., & Kamrud, K. I. (2018) · Encyclopedia of Life Sciences · doi:10.1002/9780470015902.a0027916

Nucleic acid vaccines and reverse vaccinology

Tizard, I. R. (2020) · Elsevier eBooks · doi:10.1016/b978-0-323-68299-2.00015-0

Formulations and mechanisms of action of novel vaccine adjuvants

Zughaier, S. M., Hashim, A., Khodr, N. H., Abiad, A. R. A., & AbuHaweeleh, M. N. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-15526-0.00005-6

RNA therapeutics—An evaluation of potential occupational health hazards and a strategy to establish occupational exposure limits (OELs)

Araya, S., Barle, E. L., Wiesner, L., Blum, K., Hashimoto, K., Fisher, C., Schwind, M., Galati, G., Sehner, C., Pfister, T., et al. (2025) · Journal of Occupational and Environmental Hygiene · doi:10.1080/15459624.2025.2485080

Nucleic Acid-Based Systems for Regenerative Medicine

Martín, L., & Grzela, D. P. (2025) · Springer eBooks · doi:10.1007/978-3-031-87744-5_8

Additional file 7 of Non-interfacial self-assembly of synthetic protocells

Xu, X., Guan, W., Yu, X., Xu, G., & Wang, C. (2023) · Figshare · doi:10.6084/m9.figshare.23621263

Additional file 2 of Non-interfacial self-assembly of synthetic protocells

Xu, X., Guan, W., Yu, X., Xu, G., & Wang, C. (2023) · Figshare · doi:10.6084/m9.figshare.23621248

Additional file 3 of Non-interfacial self-assembly of synthetic protocells

Xu, X., Guan, W., Yu, X., Xu, G., & Wang, C. (2023) · Figshare · doi:10.6084/m9.figshare.23621251

Additional file 4 of Non-interfacial self-assembly of synthetic protocells

Xu, X., Guan, W., Yu, X., Xu, G., & Wang, C. (2023) · Figshare · doi:10.6084/m9.figshare.23621254

Additional file 6 of Non-interfacial self-assembly of synthetic protocells

Xu, X., Guan, W., Yu, X., Xu, G., & Wang, C. (2023) · Figshare · doi:10.6084/m9.figshare.23621260

Additional file 5 of Non-interfacial self-assembly of synthetic protocells

Xu, X., Guan, W., Yu, X., Xu, G., & Wang, C. (2023) · Figshare · doi:10.6084/m9.figshare.23621257

Additional file 1 of Non-interfacial self-assembly of synthetic protocells

Xu, X., Guan, W., Yu, X., Xu, G., & Wang, C. (2023) · Figshare · doi:10.6084/m9.figshare.23621245

Multifunctional nanocomposites for precise control over drug delivery

Andretto, V. (2022) · doi:10.70675/7a7f57fez25f2z41a0z9072z3f3cc2aef2d6

mRNA-based seasonal influenza vaccines: an overview of immunogenicity, efficacy, and safety

Domnich, A., & Orsi, A. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1965512

Nucleic acid vaccines: prospects for non-viral delivery of mRNA vaccines

Deering, R. P., Kommareddy, S., Ulmer, J. B., Brito, L. A., & Geall, A. J. (2014) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.2014.901308 · Cited by 177 · see citing works

RNA: The new revolution in nucleic acid vaccines

Geall, A. J., Mandl, C. W., & Ulmer, J. B. (2013) · Seminars in Immunology · doi:10.1016/j.smim.2013.05.001 · Cited by 187 · see citing works

RNA-based vaccines

Ulmer, J. B., Mason, P. W., Geall, A. J., & Mandl, C. W. (2012) · Vaccine · doi:10.1016/j.vaccine.2012.04.060 · Cited by 183 · see citing works

Building a Better Silver Bullet: Current Status and Perspectives of Non‐Viral Vectors for mRNA Vaccines

Gu, J., Xu, Z., Liu, Q., Tang, S., Zhang, W., Xie, S., Chen, X., Chen, J., Yong, K., Yang, C., et al. (2023) · Advanced Healthcare Materials · doi:10.1002/adhm.202302409 · Cited by 19 · see citing works

Navigating the horizon of mRNA vaccines: Tracing their evolution, ensuring safety, and unveiling therapeutic potential

Yap, E. C. T. (2023) · International e-Journal of Science Medicine & Education · doi:10.56026/imu.17.3.13 · Cited by 1 · see citing works